We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Howmet Aerospace
HWM
$112B
| $22.1M | 0.05% |
+1,253,398
| New | +$25.5M |
|
302
Sabesp
SBS
$18.7B
| $22.1M | 0.05% |
10,747,033
+10,419,537
| +3,182% | +$22.4M |
|
|
CIM
303
Chimera Investment
CIM
$1B
| $22M | 0.05% |
420,957
-573,568
| -58% | -$30M |
|
|
MIME
304
DELISTED
Mimecast Limited
MIME
| $22M | 0.05% |
620,081
+170,252
| +38% | +$5.79M |
|
|
ANSS
305
DELISTED
Ansys
ANSS
| $21.9M | 0.05% |
139,645
-21,423
| -13% | -$3.43M |
|
|
EXPR
306
DELISTED
Express, Inc.
EXPR
| $21.8M | 0.05% |
152,066
+87,740
| +136% | +$12.9M |
|
307
Sanofi
SNY
$104B
| $21.1M | 0.05% |
+527,589
| New | +$22M |
|
308
InterContinental Hotels
IHG
$23.2B
| $21M | 0.05% |
326,395
+94,965
| +41% | +$6.44M |
|
309
Usana Health Sciences
USNA
$286M
| $21M | 0.05% |
244,019
+140,546
| +136% | +$10.9M |
|
310
Principal Financial Group
PFG
$24.3B
| $20.8M | 0.05% |
341,430
+333,330
| +4,115% | +$21.9M |
|
311
Weibo
WB
$1.95B
| $20.6M | 0.05% |
172,476
+23,041
| +15% | +$2.94M |
|
312
Charles River Laboratories
CRL
$12.8B
| $20.6M | 0.05% |
193,014
-231,466
| -55% | -$24.9M |
|
313
Coca-Cola Europacific Partners
CCEP
$47.9B
| $20.5M | 0.05% |
+493,095
| New | +$19.4M |
|
|
WUBA
314
DELISTED
58.com Inc
WUBA
| $20.4M | 0.05% |
255,996
-342,779
| -57% | -$27.1M |
|
315
Moog Inc Class A
MOG.A
$12.8B
| $20.4M | 0.05% |
247,764
-41,080
| -14% | -$3.55M |
|
316
Trane Technologies
TT
$106B
| $20.2M | 0.05% |
235,700
+232,900
| +8,318% | +$20.9M |
|
317
CNO Financial Group
CNO
$5.1B
| $20.1M | 0.05% |
928,871
+472,400
| +103% | +$11.1M |
|
|
HOUS
318
DELISTED
Anywhere Real Estate
HOUS
| $20.1M | 0.05% |
737,710
-354,661
| -32% | -$9.31M |
|
319
Nu Skin
NUS
$267M
| $20M | 0.05% |
+271,816
| New | +$19.3M |
|
320
Red Robin
RRGB
$152M
| $20M | 0.05% |
344,873
+41,648
| +14% | +$2.32M |
|
321
Abercrombie & Fitch
ANF
$5B
| $19.8M | 0.05% |
817,140
+363,919
| +80% | +$7.69M |
|
322
Boise Cascade
BCC
$3.02B
| $19.6M | 0.05% |
507,715
+33,300
| +7% | +$1.38M |
|
|
WDR
323
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $19.5M | 0.04% |
963,819
+647,819
| +205% | +$13.7M |
|
|
EPAY
324
DELISTED
Bottomline Technologies Inc
EPAY
| $19.4M | 0.04% |
501,463
+102,217
| +26% | +$3.81M |
|
325
DaVita
DVA
$11.7B
| $19.4M | 0.04% |
+294,159
| New | +$21.6M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.